GYENNO SCIENCE

Parkinson's disease is a common neurodegenerative disorder among the elderly. Currently, there are about 10 million people worldwide suffering from Parkinson's disease.
However, it is difficult for us to notice the presence of Parkinson's patients in our daily lives. The uncontrollable symptoms cause them significant physical discomfort and psychological burden.
GYENNO SCIENCE has planned and filmed a series of public welfare documentaries titled "Recreated Dopamine" hoping to raise public awareness, understanding, and support for this group.
This is the first installment of the series, "Belief in Tomorrow" which tells the story of a young patient diagnosed with Parkinson's disease at the age of 19, depicting nearly 20 years of his life and inner journey. The incessant tremors and involuntary movements have been like a heavy shackle that has confined his heart for years, intensifying the young man's sense of shame about his illness.
Yet, after 20 years, he has gradually gained the courage to face everything with equanimity.

"Recreated Dopamine" Parkinson's Disease Documentary Part 1 "Belief in Tomorrow" Parkinson's disease is a common neurodegenerative disorder among the elderly. Currently, there are about 10 million people worldwide suffering from Parkinson...

In this study, the quantitative assessment of non-motor symptoms of Parkinson's disease (hallucinations) was realized through VR.
Matrix Pro developed by GYENNO Science utilized machine vision and multiple fusion perceptual technologies in combination with artificial intelligence algorithms to intelligently quantify motor symptoms on the MDS-UPDRS III classic scale.

Numerosity estimation of virtual humans as a digital-robotic marker for hallucinations in Parkinson’s disease - Nature Communications Virtual reality, robotics and digital online technologies reveal heightened visual overestimation when estimating the number of humans, indexing presence hallucinations in healthy participants and patients with Parkinson’s disease.

Innovative therapies continue to emerge, which is exciting. But Parkinson's disease is still subject to under-diagnosis and misdiagnosis in many countries. That's what we're doing, and GYENNO is developing a range of innovative technologies to enable intelligent quantitative assessment of Parkinson's disease. This enables a complete pathway from assessment to diagnosis to treatment.😃

Parkinson's Drug Reduces Disease Markers in Breakthrough Trial A novel therapy designed to clear toxic clumps of a protein thought to be responsible for Parkinson's disease has shown promise in early clinical trials.

An incredible milestone and just the beginning of a very exciting future!👏

Eye scans detect signs of Parkinson's disease up to seven years before symptoms emerge A team led by Siegfried Wagner and Pearse Keane of Moorfields Eye Hospital and UCL Institute of Ophthalmology (and spanning UCL institutions) has identified markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation. This is the first ...

AI technology has the potential to transform early detection and assessment of many diseases.

Parkinson's disease could be detected early with AI scans, scientists say The study detected physical differences in the eyes of people with Parkinson's and those without the condition.

Cool! GYENNO is also using AI technology to solve the problem of not being able to quantitatively assess Parkinson's disease! We hope to help more patients out of their predicament in the future.

AI discovers 4 types of Parkinson’s disease, paving way for personalized treatments LONDON— Personalized treatments for Parkinson's disease may soon be a reality. Scientists have used artificial intelligence (AI) to identify different

I think if it has something to do with the intense collision? Boxing is the same way.

Playing Football Might Elevate Parkinson’s Risk - Neuroscience News Researchers identified a potential link between playing tackle football and an increased risk of Parkinson’s disease (PD).

It's important to adjust a positive mindset as much as possible to slow the progression of Parkinson's disease through training and maintaining good communication with your doctor about your treatment!

A Pianist Adapts to Life With Parkinson’s Disease In the fall of 2018, the pianist Nicolas Hodges noticed his body shaking. He brought it up at a routine doctor’s appointment in Tübingen, Germany, where he

More than 60% of Parkinson's disease patients are diagnosed with high blood pressure.
Scientists from China analysed two years of clinical results using data from the Parkinson's Disease Progression Marker Initiative (PDPMI).

Parkinson's progression not affected by blood pressure... More than 60% of Parkinson's disease patients are diagnosed with high blood pressure, leading researchers to explore a possible connection.

Follow Daily Parkinson's Cutting Edge News

Key Mechanism in Parkinson's Disease Identified by Researcher Yulan Xiong and her team have made a novel discovery about how a gene responsible for Parkinson's Disease in many cases can be regulated. Yulan

Connecticut researchers uncover regulator compound with potential to treat Parkinson's disease

Connecticut researchers uncover regulator compound with potential to treat Parkinson's disease: Report An assistant professor at UConn Health and a team of researchers have reportedly discovered a regulator compound which hold the potential to treat Parkinson's disease.

Beyond Reward, Dopamine Drives Movement

Beyond Reward, Dopamine Drives Movement - Neuroscience News Researchers discovered a genetic subtype of dopamine neurons that fires during movement, contrary to the long-standing belief that dopamine neurons primarily respond to rewards.

GYENNO SCIENCE updated their phone number.